首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1439626

人工水晶体 - 全球市场考量、竞争格局、市场预测（2030 年）

Intraocular Lens - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按订单生产 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

预计，2023年全球人工水晶体市场规模将达38.5亿美元，到2030年将达到51.3亿美元，2024-2030年预测期间复合年增长率为4.89%。眼部疾病盛行率上升、世界各国政府加强控制和治疗失明、人工水晶体技术进步、老年人口数量增加等是人工水晶体需求快速成长的主要原因。预计将有助于扩大产品需求，进而推动2024-2030 年预测期内人工水晶体市场的成长。

人工水晶体市场动态

由于多种原因，人工水晶体市场的产品需求不断增加，其中主要原因之一是眼部疾病的盛行率不断增加。屈光不正、老年黄斑部病变、白内障、糖尿病视网膜病变和青光眼等眼部疾病的盛行率日益增加，是人工水晶体市场特别重要的驱动因素。大多数60岁以上的人患有各种类型的慢性眼疾，需要进行眼科手术。视力障碍是影响身心健康的全球性健康问题。视力受损的人特别容易患慢性病、意外、社交退缩、忧郁和死亡。根据世界卫生组织 (WHO) 的数据，2020 年至少有 22 亿人患有近距离视力或远端视力障碍。据同一消息来源称，到 2020 年，大约有 10 亿人患有屈光不正、白内障、青光眼以及由于角膜混浊导致的中度屈光不正而未得到治疗。因此，如此庞大的眼疾患者群体使其成为人工水晶体市场公司的潜在目标。

此外，根据2019年世界卫生报告，全球每年约有1000万例白内障手术，其中人工水晶体广泛使用，手术率每年每百万人100至100例，在6000例之间波动。因此，由于眼部疾病盛行率的增加和白内障患者数量的增加，人工水晶体的全球渗透率将在预测期内（2024-2030年）刺激全球人工水晶体市场。

另一个可能推动人工水晶体市场成长的因素是人工水晶体开发的技术进步。由于眼部疾病盛行率不断上升，对人工水晶体的需求不断增加，企业可以增加对人工水晶体技术进步的投资。

公司与眼科界保持持续联繫，不时进行调查，以瞭解患者需求并相应调整研发。活跃在这一领域的公司不断致力于推出各种材料、形状和尺寸的人工水晶体，以解决术后亮度和术后后囊膜浑浊 (PCO) 等问题。这些进步体现在市场上的各种尖端人工水晶体中，引入了新的水晶体设计，例如蓝光截止人工水晶体、消色差人工水晶体和復曲面人工水晶体。术后光功率变化为患者提供了更个人化的方法，使他们能够接受根据其视力矫正方面的特定需求量身定制的治疗。

技术进步促进了新型人工水晶体的发展，例如三焦点、四焦点、扩展景深 (EDOF) 和可调节人工水晶体，这些晶状体连同改进的光学元件和像差分布，可以在任何距离使用。现在我们可以提供不戴眼镜的视力。人工水晶体的优点也转化为市场的高需求，越来越多的公司在临床试验中开发采用新技术的人工水晶体就证明了这一点，例如 Anew Optics 的 Zephyr IOL。例如，美国推出的新技术多焦点人工水晶体是爱尔康 PanOptix，这是一种具有出色远、中、近距离视力的三焦点水晶体。其他人工水晶体正在 FDA 批准中，具有增强的选项，可优化覆盖范围并最大限度地减少光晕和眩光。 2022年，IC8（AcuFocus）完成FDA临床试验并向FDA提交上市前核准申请。因此，随着这些技术的进步，更多的产品将在市场上推出，并且在预测期内人工水晶体市场的成长前景是光明的。

本报告研究和分析了全球人工水晶体市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

推动人工水晶体市场的因素
- 眼部疾病盛行率上升
- 世界各国政府加强控制和治疗失明
- 人工水晶体技术的进步
- 老年人口迅速增加
人工水晶体市场的抑制因素与挑战
- 与人工水晶体相关的术后併发症
- 缺乏优质镜片覆盖范围
人工水晶体市场机遇
- 新兴市场尚未开发的潜力
- 提高对人工水晶体的认识

第5章人工水晶体市场波特五力分析

第6章COVID-19对人工水晶体市场的影响分析

第7章人工水晶体市场布局

依产品类型
- 单焦点人工水晶体
- 优质人工水晶体
- 其他
依材质
- 聚甲基丙烯酸甲酯
- 疏水性丙烯酸人工水晶体
- 亲水性丙烯酸人工水晶体
按最终用户
- 医院
- 门诊手术中心
- 眼科诊所
按地区
- 北美
- 欧洲
- 亚太地区
- 其他领域

第 8 章人工水晶体市场：全球公司占有率分析 - 3 至 5 家主要公司

第9章人工水晶体市场公司及产品概况

Johnson & Johnson
HOYA GROUP
Alcon Inc
Carl Zeiss Meditec AG
Bausch & Lomb
Rayner Intraocular Lenses Limited
Eyekon Medical Inc
Lenstec, Inc
HumanOptics AG
STAAR Surgical Company
Aurolab
PhyIOL S.A.
Care Group
Tekia Inc
Omni Lens Pvt. Ltd
MORCHER® GmbH
Ophtec BV
SIFI S.p.A.
Excellent Hi-Care Pvt. Ltd
Hanita Lenses

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

简介目录图表

Product Code: DIMDCL0462

Intraocular Lenses Market By Product Type (Monofocal IOLs [Aspheric Monofocal IOLs And Spheric Monofocal IOLs], Premium Iols [Multifocal Iols, Accomodating Iols, And Extended Depth-Of-Focus IOLs], And Others), By Material (Polymethyl Methacrylate, Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Ophthalmology Clinics), and by geography is expected to grow at a steady CAGR (forecast period- 2024-2030) owing to increasing prevalence of ocular diseases rising technological advancements in new intraocular lenses

Global Intraocular Lens Market was valued at USD 3.85 billion in 2023, growing at a CAGR of 4.89% during the forecast period from 2024 to 2030 to reach USD 5.13 billion by 2030. The demand for intraocular lenses is witnessing a surge primarily due to the rising prevalence of eye diseases, increasing initiatives by various governments across the globe in controlling and treating blindness, technological advancements in IOLs, and the increasing geriatric population who are more susceptible to ocular ailments which are expected to contribute in the growing product demand thereby boosting the growth of the of the intraocular lens market during the forecast period from 2024-2030.

Intraocular Lens Market Dynamics:

The intraocular lenses market is experiencing increased product demand for a variety of reasons, one of the main reasons being the increase in the prevalence of ocular diseases. Increasing prevalence of eye diseases such as refractive error, age-related macular degeneration, cataracts, diabetic retinopathy, and glaucoma is a major driver of the intraocular lens market in particular. The majority of people over the age of 60 are affected by various types of eye problems that are chronic and require eye surgery. Visual impairment is a global health problem that affects physical and mental health. Visually impaired people are at particular risk of chronic illness, accidents, social withdrawal, depression, and death. According to the World Health Organization, in 2020, at least 2.2 billion people suffered from short- or long-distance visual impairment. According to the same source, in 2020, about 1 billion people had moderate refractive error due to untreated refractive error (88.4 million), cataract (94 million), glaucoma (7.7 million), and corneal opacity (4.2 million). Therefore, the presence of such large patient pool with ocular diseases are potential targets for companies operating in the IOL market.

Additionally, according to the 2019 World Health Report, approximately 10 million cataract surgeries are performed worldwide each year wherein IOLs are extensively used, and the rate of surgeries fluctuates between 100 and 6,000 per million people annually. Therefore, the increasing global acceptance of IOL and the increasing number of patients suffering from cataracts due to the increased prevalence of eye diseases will stimulate the global intraocular lens market during the forecast period (2024-2030).

Another contributing factor that may be responsible for the growth of the intraocular lens market is the technological advancements in the development of IOLs. Due to the rising prevalence of eye disease has increased the demand for IOLs, allowing companies to invest more in the technological advances in intraocular lenses.

Companies are in constant contact with the ophthalmology community and conduct occasional surveys to understand the needs of their patients and adjust their R&D accordingly. Companies operating in this domain are continuously working on the introduction of IOLs of various materials, shapes and sizes to address issues such as post-operative glistening and post-operative posterior capsule opacity (PCO). These advances were reflected by the variety of state-of-the-art IOLs available in the market, introducing new design lenses such as blue light blocking IOLs, aberration-free IOLs, and toric IOLs. Postoperative changes in optical power offer a more personalized approach for patients thereby enabling them to receive treatment catering to their specific needs in terms of vision correction.

Technological advancements have led to the development of newer IOLs comprising trifocal, quadrifocal, extended-depth-of-focus (EDOF) and adjustable IOLs that are capable in providing spectacle-free vision at all distances, along with improvement in optics and aberration profiles. Advantages associated with IOLs have also translated into their high demand in the market which is evident by the fact that more companies are developing IOLs with new technology that are in clinical trials such as Zephyr IOL by Anew Optics. For instance, one of the latest technologically advanced multifocal IOLs available in the United States is the Alcon PanOptix, a trifocal lens with good far vision, intermediate vision, and near vision. Other IOLs are in the FDA-approved pipeline with enhanced options to optimize range and minimize halos and glare. In 2022, IC8 (AcuFocus) completed the FDA's clinical trials and submitted a pre-marketing approval application to the FDA. Therefore, these technological advancements have led to the more products reaching the market thereby presenting a positive growth outlook for the IOL market during the forecast period.

However, limitations associated with post-operative complications associated with intraocular lens and lack of coverage of premium lens may prove to be challenging factors for the intraocular lenses market growth.

Along with the factors mentioned above, the intraocular lenses market witnessed a period of slow growth due to the COVID-19 pandemic. The lockdown implemented by various governments worldwide to curb the spread of the COVID-19 infection resulted in suspension of various surgeries and outpatient consultations across virtually all medical specialties including ophthalmology. The elective procedures were postponed as the number of new COVID-19 cases had reached a peak, many clinics were closed, and the cataract surgeries were down by approximately half of the surgical volumes compared to previous years resulting in the low demand of IOLs. However, the approval of various COVID-19 vaccines and the efforts in the direction of mass vaccination has paved the way for recovery in revenue generation in the IOLs market, thereby presenting a positive growth outlook of the IOLs market during the forecast period.

Intraocular Lens Market Segment Analysis:

Intraocular Lenses Market by Product Type (Monofocal IOLs [Aspheric Monofocal IOLs and Spheric Monofocal IOLs], Premium IOLs [Multifocal IOLs, Accommodating IOLs, And Extended Depth-Of-Focus IOLs], and Others), by Material (Polymethyl Methacrylate, Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the Intraocular Lens Market, the monofocal IOLs category is expected to hold the largest market share in the IOLs market during the forecast period. Monofocal IOLs are further sub-segmented into aspheric monofocal IOLs and spheric monofocal IOLs. Between the two, aspherical monofocal IOLs are expected to register a faster growth in CAGR during the forecast period. This can be attributed to the features offered by these type of lenses such as improved contrast sensitivity, superior night driving ability, and enhanced functional vision. These features have been immensely popular among end users thereby resulting in their higher adoption.

Moreover, aspheric monofocal IOLs are easy to insert, induces limited or zero spheric aberration, and create very effective contrast sensitive optical image for patients. In addition to that, the presence of major players such as ZIESS with products like ZEISS CT LUCIA, ZEISS CT ASPHINA and Alcon with product like Alcon IQ Aspheric IOL dominate the market.

Therefore, all the factors mentioned above indicate towards the popularity of aspheric monofocal IOLs in the market, thereby making them the most popular product type in monofocal IOLs category.

Asia-Pacific is expected to register fastest growth in the Overall Intraocular Lenses Market:

Among all the regions, Asia-Pacific is expected to account for the fastest growth in terms of CAGR with 5.90% in the intraocular lenses market. The key driving factors of the Asia -Pacific Intraocular Lens Market are increasing prevalence of ocular diseases, rising investments and big collaborative expansions by key players in the region. Moreover, the increased healthcare awareness is also driving the growth of the APAC Intraocular Lenses market.

According to the data cited by the World Health Organization, in 2020, an estimated 596 million people worldwide had distant visual impairment, of which 43 million were blind. The majority of those affected (90%) live in low- and middle-income countries (LMIC). The study further mentioned that South Asia had the highest overall age-standardized prevalence of moderate to severe vision impairment. It was reported that the highest number of cases associated with blindness was observed in South Asia (11.9 million) followed by East Asia (9.1 million), and Southeast Asia (5.9 million) which was attributed to the presence of large population in the region, in general. The data further stated that majority of the cases associated with vision impairment were related with cataracts. Therefore, the presence of large patient pool has prompted international organizations and governments to provide better access to eye care thereby boosting the demand for IOLs in the region.

Moreover, due to the presence of large patient population of ocular diseases in the APAC countries, VISION 2020, an initiative by the World Health Organization and the International Agency for the Prevention of Blindness was launched in 1999. Under this initiative, which was spread over the years, many countries devised national plans in order to deal with the disease burden associated with ocular diseases. For instance, in 2011, Lions Clubs International Foundation (LCIF), in partnership with the People's Republic of China, initiated a new phase of their campaign in China known as SightFirst China Action (SFCA), which aims at preventing blindness. Since its formation in 1997, the foundation invested more than USD 30.8 million for more than 5 million cataract surgeries and upgrading of 300 eye care institutions and above. In addition, the Chinese government-funded more than USD 200 million to support their campaign.

Therefore, such efforts in the direction of providing proper eye care to such large patient population in the region by offering accessible healthcare services and collaborations among manufacturers and organizations are expected to stimulate the growth of the APAC intraocular lens market.

Intraocular Lenses Market Key Players:

Some of the key market players operating in the intraocular lenses market includes Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER? GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others.

Recent Developmental Activities in Intraocular Lens Market:

In September 21, 2022, ZEISS Medical Technology introduced industry-first, integrated solutions that bring further value to the ZEISS Medical Ecosystem at ZEISS Innovation Week. The newly introduced ZEISS CT LUCIA 621* monofocal IOL features the patented ZEISS Optic (ZO) Asphericity Concept with its uniquely forgiving design to deliver excellent visual outcomes for a broad range of patients and surgical situations.

In February 2022, Johnson & Johnson Vision received FDA approval for next-generation monofocal intraocular lens - Tecnis Eyhance(TM) and Tecnis Eyhance(TM) Toric Ii IOLS, for the treatment of cataract patients.

In January 07, 2022 Alcon Inc commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the US - the AcrySof? IQ VivityTM IOL (Vivity).

Key Takeaways from the Intraocular Lens Market Report Study

Market size analysis for current intraocular lenses market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the intraocular lenses market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Intraocular Lens Market.

Various opportunities available for the other competitor in the Intraocular Lens Market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current intraocular lenses market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for intraocular lenses market growth in the coming future?

Target Audience who can be benefited from this Intraocular Lenses Market Report Study

Intraocular Lens products providers

Research organizations and consulting companies

Intraocular Lens-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in intraocular lenses

Various End-users who want to know more about the Intraocular Lens market and latest technological developments in the Intraocular Lens market.

Frequently Asked Questions for Intraocular Lens Market:

1. What is an Intraocular Lens?

An intraocular lens (IOL) is an implant which acts a replacement for the natural lens of eyes and takes over the image-focusing function in the eye.

2. What is the market for Global Intraocular Lens?

Global Intraocular Lens Market was valued at USD 3.85 billion in 2023, growing at a CAGR of 4.89% during the forecast period from 2024 to 2030 to reach USD 5.13 billion by 2030.

3. What are the drivers for Global Intraocular Lens Market?

The demand for intraocular lenses is witnessing a surge primarily due to certain market growth drivers such as the rising prevalence of eye diseases, increasing initiatives by various governments across the globe in controlling and treating blindness, technological advancements in IOLs, and the increasing geriatric population who are more susceptible to ocular ailments which are expected to contribute in the growing product demand thereby boosting the growth of the of the intraocular lens market during the forecast period from 2024-2030.

4. Who are the key players operating in Global Intraocular Lens Market?

5. Which region will register the fastest growth in Intraocular Lens market?

APAC is predicted to register the fastest growth the intraocular lenses market because of the high prevalence of diabetes, presence of large patient population suffering from ocular diseases, rising investments and big collaborative expansions by key players in the region. Moreover, the increased healthcare awareness is also driving the growth of the APAC Intraocular Lenses market.

1.Intraocular Lens Market Report Introduction

2.Intraocular Lens Market Executive Summary

2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

3.1 The United States
3.2 Europe
3.3 Japan
3.4 China

4. Intraocular Lens Market Key Factors Analysis

4.1 Intraocular Lens Market Drivers
- 4.1.1 Rising Prevalence of Eye Diseases
- 4.1.2 Increasing Initiatives by Various Governments Across the Globe in Controlling and Treating Blindness
- 4.1.3 Technological Advancements in IOLs
- 4.1.4 Surge in Geriatric Population
4.2 Intraocular Lens Market Restraints and Challenges
- 4.2.1 Post-operative Complications Associated with Intraocular Lens
- 4.2.2 Lack of Coverage of Premium Lens
4.3 Intraocular Lens Market Opportunities
- 4.3.1 Untapped Potential of Emerging Markets
- 4.3.2 Increasing awareness Toward Intraocular Lens

5. Intraocular Lens Market Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Intraocular Lens Market

7. Intraocular Lens Market Layout

7.1 By Product Type
- 7.1.1 Monofocal Intraocular Lenses
  - 7.1.1.1 Aspheric Monofocal IOLs
  - 7.1.1.2 Spheric Monofocal IOLs
- 7.1.2 Premium IOLS
  - 7.1.2.1 Multifocal IOLs
  - 7.1.2.2 Accommodating IOLs
  - 7.1.2.3 Extended Depth-of-Focus IOLs
- 7.1.3 Others
7.2 By Material
- 7.2.1 Polymethyl Methacrylate
- 7.2.2 Hydrophobic Acrylic IOLs
- 7.2.3 Hydrophilic Acrylic IOLs
- 7.2.4 Others
7.3 By End User
- 7.3.1 Hospitals
- 7.3.2 Ambulatory Surgical Centers
- 7.3.3 Ophthalmology Clinics
7.4 By Geography
- 7.4.1 North America
  - 7.4.1.1 North America Intraocular Lens Market, by Product Type
  - 7.4.1.2 North America Intraocular Lens Market, by Material
  - 7.4.1.2 North America Intraocular Lens Market, by End User
  - 7.4.1.4 North America Intraocular Lens Market, by Country
  - 7.4.1.4.1 United States
  - 7.4.1.4.2 Canada
  - 7.4.1.4.3 Mexico
- 7.4.2 Europe
  - 7.4.2.1 Europe Intraocular Lens Market, by Product Type
  - 7.4.2.2 Europe Intraocular Lens Market, by Material
  - 7.4.2.2 Europe Intraocular Lens Market, by End User
  - 7.4.2.4 Europe Intraocular Lens Market, by Country
  - 7.4.2.4.1 France
  - 7.4.2.4.2 Germany
  - 7.4.2.4.3 United Kingdom
  - 7.4.2.4.4 Italy
  - 7.4.2.4.5 Spain
  - 7.4.2.2.6 Russia
  - 7.4.2.2.7 Rest of Europe
- 7.4.3 Asia-Pacific
  - 7.4.3.1 Asia-Pacific Intraocular Lens Market, by Product Type
  - 7.4.3.2 Asia-Pacific Intraocular Lens Market, by Material
  - 7.4.3.2 Asia-Pacific Intraocular Lens Market, by End User
  - 7.4.3.4 Asia-Pacific Intraocular Lens Market, by Country
  - 7.4.3.4.1 China
  - 7.4.3.4.2 Japan
  - 7.4.3.4.3 India
  - 7.4.3.4.4 Australia
  - 7.4.3.4.5 South Korea
  - 7.4.3.4.6 Rest of Asia Pacific
- 7.4.4 Rest of the World (RoW)
  - 7.4.4.1 RoW Intraocular Lens Market, by Product Type
  - 7.4.4.2 RoW Intraocular Lens Market, by Material
  - 7.4.4.2 RoW Intraocular Lens Market, by End User
  - 7.4.4.4 RoW Intraocular Lens Market, by Region
  - 7.4.4.4.1 Middle East
  - 7.4.4.4.2 Africa
  - 7.4.4.4.3 South America

8. Intraocular Lens Market Global Company Share Analysis - Key 3-5 Companies

9. Intraocular Lens Market Company and Product Profiles

9.1 Johnson & Johnson
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4 Product Listing
- 9.1.5. Entropy
9.2 HOYA GROUP
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4 Product Listing
- 9.2.5. Entropy
9.3 Alcon Inc
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4 Product Listing
- 9.3.5. Entropy
9.4 Carl Zeiss Meditec AG
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4 Product Listing
- 9.4.5. Entropy
9.5 Bausch & Lomb
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4 Product Listing
- 9.5.5. Entropy
9.6 Rayner Intraocular Lenses Limited
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4 Product Listing
- 9.6.5. Entropy
9.7 Eyekon Medical Inc
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4 Product Listing
- 9.7.5. Entropy
9.8 Lenstec, Inc
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4 Product Listing
- 9.8.5. Entropy
9.9 HumanOptics AG
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4 Product Listing
- 9.9.5. Entropy
9.10 STAAR Surgical Company
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4 Product Listing
- 9.10.5. Entropy
9.11 Aurolab
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4 Product Listing
- 9.11.5. Entropy
9.12 PhyIOL S.A.
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4 Product Listing
- 9.12.5. Entropy
9.13 Care Group
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4 Product Listing
- 9.13.5. Entropy
9.14 Tekia Inc
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4 Product Listing
- 9.14.5. Entropy
9.15 Omni Lens Pvt. Ltd
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4 Product Listing
- 9.15.5. Entropy
9.16 MORCHER® GmbH
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4 Product Listing
- 9.16.5. Entropy
9.17 Ophtec BV
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4 Product Listing
- 9.17.5. Entropy
9.18 SIFI S.p.A.
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4 Product Listing
- 9.18.5. Entropy
9.19 Excellent Hi-Care Pvt. Ltd
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4 Product Listing
- 9.19.5. Entropy
9.20 Hanita Lenses
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4 Product Listing
- 9.20.5. Entropy